0
JAMA Clinical Challenge | Clinician's Corner

Unilateral Proptosis FREE

Javier Munoz, MD; Razelle Kurzrock, MD
[+] Author Affiliations

Author Affiliations: Investigational Cancer Therapeutics (Phase I Clinical Trials Program), MD Anderson Cancer Center, Houston, Texas.


JAMA Clinical Challenge Section Editor: Huan J. Chang, MD, Contributing Editor. We encourage authors to submit papers for consideration as a JAMA Clinical Challenge. Please contact Dr Chang at tina.chang@jamanetwork.org

More Author Information
JAMA. 2013;309(6):605-606. doi:10.1001/jama.2013.233.
Text Size: A A A
Published online

A 40-year-old man presents with left periorbital swelling and pain,which developed gradually over 2 months with no history of trauma, fever, or recent sinusitis. He has no previous medical illness and is not taking any medications. The patient denies diplopia and exposure to allergic or contact irritants. Physical examination confirms chemosis and left proptosis (Figure 1) without pulsation or bruit. The patient is neurologically intact, including normal pupillary response and extraocular movements. Laboratory studies are unremarkable, including normal complete blood cell count findings, negative blood cultures, and normal thyroid-stimulating hormone values.

Place holder to copy figure label and caption
Figure 1. Proptosis, chemosis, and periorbital swelling of the left eye.
Grahic Jump Location

  • A. Measure levels of free thyroid hormone and start radioactive iodine

  • B. Request computed tomography of the head, with contrast

  • C. Request orbital venography andarteriography

  • D. Start intravenous antibiotics, including antifungal therapy

See www.jama.com for online Clinical Challenge.

High-grade neuroendocrine carcinoma involving the left ethmoid and frontal sinuses.

B. Request computed tomography of the head, with contrast.

The key feature in this case is to recognize that malignancy is part of the differential diagnosis of unilateral proptosis. The first priority, after obtaining thyroid function studies, is to perform imaging to rule out a retro-orbital infiltrative process.

Although the terms proptosis and exophthalmos are generally used interchangeably, it has been suggested that exophthalmos is an endocrine-related ocular protrusion and proptosis is a nonendocrine-related condition.1 The differential diagnosis for proptosis includes Graves disease, Wegener granulomatosis, sarcoidosis, idiopathic orbital inflammation, orbital myositis, infection, and malignancy.2 Treatment for most of those conditions entails systemic immunosuppression; hence, neoplastic and infectious etiologies must first be ruled out. Thyroid ophthalmopathy, an autoimmune inflammatory orbital disease, is the most common cause of exophthalmos in adults.3 Most patients with thyroid ophthalmopathy do not require any particular treatment; nevertheless, steroids, radiation, and surgical decompression may be used in severely refractory cases to avoid potential sight-threatening complications.

Orbital soft tissues are divided into anterior and posterior compartments by the orbital septum. Orbital cellulitis is a deep soft tissue infection posterior to the orbital septum, whereas preseptal cellulitis is a superficial soft tissue infection anterior to the septum. Most cases of orbital cellulitis are secondary to direct extension of bacterial sinusitis and usually present with acute onset of blurred vision, diplopia, fever, and exophthalmos. Although patients with orbital and preseptal cellulitis may have a similar appearance, patients with preseptal cellulitis do not develop exophthalmos. Mucormycosis is an aggressive and potentially life-threatening fungal infection that must be ruled out in any immunocompromised patient presenting with orbital cellulitis.4 Neuroendocrine tumors are a heterogeneous group of malignancies generally divided into high-grade, intermediate-grade, and low-grade based on cytologic and histologic features, such as the Ki-67 marker of proliferative activity.5 According to data from the Surveillance, Epidemiology, and End Results program, the incidence of neuroendocrine tumors was 5.25 cases per 100 000 persons per year in 2004, with the most common locations being the gastrointestinal tract and lungs. Other primary locations, such as the paranasal sinuses, are rare.6 Systemic chemotherapy is recommended for unresectable or advanced high-grade neuroendocrine carcinomas, although response rates are modest.5

Computed tomography is useful for assessing the integrity of osseous structures; nevertheless, magnetic resonance imaging is a superior modality for delineating soft tissue tumors and the extent of neoplastic or infectious conditions affecting the paranasal sinuses.6 Imaging using contrast-enhanced computed tomography, which is superior to computed tomography without contrast for confirming intracranial pathology, would show enhancing tumor and rule out the presence of metastatic disease to the brain. Invasive orbital arteriography and venography are low-yield imaging studies in this setting but are nevertheless an essential part of the workup of orbital arteriovenous malformations.7 Arteriovenous malformation is a rare cause of proptosis and is usually accompanied by pulsation or bruit, which typically develops gradually, sometimes over a period of years, after history of previous trauma.8

In this patient, computed tomography and magnetic resonance imaging of the head showed a mass extending into the left ethmoid and frontal sinuses (Figure 2). The patient underwent sinus exploration confirming high-grade neuroendocrine carcinoma; he received chemotherapy, radiotherapy, and frontal craniotomy but later developed recurrence and is currently receiving palliative chemotherapy.

Place holder to copy figure label and caption
Figure 2. Computed tomography scan showing a mass extending into the left ethmoid and left frontal sinuses.
Grahic Jump Location

Corresponding Author: Javier Munoz, MD, Investigational Cancer Therapeutics (Phase I Clinical Trials Program), MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 455, Houston, TX 77030 (jlmunoz@mdanderson.org).

Conflict of Interest Disclosures: The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported.

Additional Contributions: We thank the patient for providing permission to share his information.

Epstein O, Perkin D, Cookson J,  et al.  Clinical Examination. 3rd ed. St Louis, MO: Mosby; 2003
Lutt JR, Lim LL, Phal PM, Rosenbaum JT. Orbital inflammatory disease.  Semin Arthritis Rheum. 2008;37(4):207-222
PubMed   |  Link to Article
Levy J, Sobel R, Marcus M, Lifshitz T. Thyroid ophthalmopathy.  Minerva Endocrinol. 2005;30(4):247-265
PubMed
Lanternier F, Dannaoui E, Morizot G,  et al; French Mycosis Study Group.  A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007).  Clin Infect Dis. 2012;54(suppl 1)  S35-S43
PubMed   |  Link to Article
National Comprehensive Cancer Network (NNCN).  Neuroendocrine Tumors. NCCN website. http://www.nccn.org/index.asp. Accessed February 21, 2012
Yao JC, Hassan M, Phan A,  et al.  One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.  J Clin Oncol. 2008;26(18):3063-3072
PubMed   |  Link to Article
Dallow RL, Momose KJ, Weber AL, Wray SH. Comparison of ultrasonography, computerized tomography (EMI scan), and radiographic techniques in evaluation of exophthalmos.  Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1976;81(2):305-322
PubMed
Warrier S, Prabhakaran VC, Valenzuela A, Sullivan TJ, Davis G, Selva D. Orbital arteriovenous malformations.  Arch Ophthalmol. 2008;126(12):1669-1675
PubMed   |  Link to Article

Figures

Place holder to copy figure label and caption
Figure 1. Proptosis, chemosis, and periorbital swelling of the left eye.
Grahic Jump Location
Place holder to copy figure label and caption
Figure 2. Computed tomography scan showing a mass extending into the left ethmoid and left frontal sinuses.
Grahic Jump Location

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Epstein O, Perkin D, Cookson J,  et al.  Clinical Examination. 3rd ed. St Louis, MO: Mosby; 2003
Lutt JR, Lim LL, Phal PM, Rosenbaum JT. Orbital inflammatory disease.  Semin Arthritis Rheum. 2008;37(4):207-222
PubMed   |  Link to Article
Levy J, Sobel R, Marcus M, Lifshitz T. Thyroid ophthalmopathy.  Minerva Endocrinol. 2005;30(4):247-265
PubMed
Lanternier F, Dannaoui E, Morizot G,  et al; French Mycosis Study Group.  A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007).  Clin Infect Dis. 2012;54(suppl 1)  S35-S43
PubMed   |  Link to Article
National Comprehensive Cancer Network (NNCN).  Neuroendocrine Tumors. NCCN website. http://www.nccn.org/index.asp. Accessed February 21, 2012
Yao JC, Hassan M, Phan A,  et al.  One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.  J Clin Oncol. 2008;26(18):3063-3072
PubMed   |  Link to Article
Dallow RL, Momose KJ, Weber AL, Wray SH. Comparison of ultrasonography, computerized tomography (EMI scan), and radiographic techniques in evaluation of exophthalmos.  Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1976;81(2):305-322
PubMed
Warrier S, Prabhakaran VC, Valenzuela A, Sullivan TJ, Davis G, Selva D. Orbital arteriovenous malformations.  Arch Ophthalmol. 2008;126(12):1669-1675
PubMed   |  Link to Article
CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles